Nora Henrikson, PhD, MPH

Nora Henrikson

"I believe that our members are the key to helping us know how to deliver the best care possible."

Nora Henrikson, PhD, MPH

Associate Investigator, Kaiser Permanente Washington Health Research Institute

Twitter: @norahenrikson

Biography

Nora Henrikson, PhD, MPH, conducts research that seeks to improve the lives of people with cancer and their families. Her current projects include interventions to mitigate cancer-related financial hardship and to improve communication with families about genetic risk. In addition, she leads KPWA’s participation in the Kaiser Permanente Evidence-Based Practice Center.

Dr. Henrikson joined Kaiser Permanente Washington Health Research Institute as a research associate in 2010.

RESEARCH INTERESTS AND EXPERIENCE

  • Behavioral Science

    Social/behavioral quantitative and qualitative research; intervention design; systematic review and evidence synthesis; epidemiology; patient-provider communication

  • Cancer

    Genetic testing for cancer risk, cancer-related financial hardship

  • Social Determinants of Health

    Financial hardship

  • Public Health Genetics

    Social, ethical, and policy implications of genomics and precision health

  •  

Recent publications

Henrikson NB, Anderson ML, Dickerson J, Ewing JJ, Garcia R, Keast E, King DA, Lewis C, Locher B, McMullen C, Norris CM, Petrik AF, Ramaprasan A, Rivelli JS, Schneider JL, Shulman L, Tuzzio L, Banegas MP. The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship. Trials. 2022 May 13;;23(1):402. doi: 10.1186/s13063-022-06344-3. PubMed

Leppig KA, Rahm AK, Appelbaum P, Aufox S, Bland ST, Buchanan A, Christensen KD, Chung WK, Wright-Clayton E, Crosslin D, Denny J, DeVange S, Gordon A, Green RC, Hakonarson H, Harr MH, Henrikson NB, Hoell C, Holm IA, Kullo IJ, Jarvik GP, Lammers PE, Larson EB, Lindor NM, Marasa M, Myer MF, Perez E, Peterson JF, Pratap S, Prows CA, Ralston JD, Rasouly HM, Roden DM, Sharp RR, Singh R, Shaibi G, Smith ME, Sturm A, Thiese HA, Van Driest SL, Williams J, Williams MS, Wynn J, Zawatsky CL, Weisner GL. The reckoning: the return of genomic results to 1444 participants across the eMERGE3 Network. Genet Med. 2022 May;24(5):1130-1138. doi: 10.1016/j.gim.2022.01.015. Epub 2022 Feb 23. PubMed

Moldestad M, Sayre G, Rinne S, Kaboli PJ, Reddy A, Sanders KM, Mao J, Henrikson NB, Sterling R, Nelson KM, Wong ES. Perspectives on training and working in the VHA: implications for primary care physician recruitment and retention. Acad Med. 2022 Feb 8. doi: 10.1097/ACM.0000000000004619. Online ahead of print. PubMed

Kauffman TL, Prado YK, Reyes AA, Zepp JM, Sawyer J, White LL, Martucci J, Salas SB, Vertrees S, Rope AF, Weinmann S, Henrikson NB, Lee SS, Feigelson HS, Hunter JE. Feasibility of a traceback approach for using pathology specimens to facilitate genetic testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) study protocol. J Pers Med. 2021 Nov 13;11(11):1194. doi: 10.3390/jpm11111194. PubMed

Sterling R, Rinne ST, Reddy A, Moldestad M, Kaboli P, Helfrich CD, Henrikson NB, Nelson KM, Kaminetzky C, Wong ES. Identifying and prioritizing workplace climate predictors of burnout among VHA primary care physicians. J Gen Intern Med. 2021 Jul 29. doi: 10.1007/s11606-021-07006-x. Online ahead of print. PubMed

DiNucci A, Henrikson NB, Jonas MC, Basra S, Blasi P, Brown J, Esplin ED, Hassen D, Hao J, Hu Y, Klinger T, Ladd I, Leppig K, Lewis M, Meyer M, Ney S, Ramaprasan A, Romagnoli K, Salvati Z, Scrol A, Schwiter R, Sheridan L, Somasundaram B, Suwannarat P, Wagner JK, Rahm AK. Feasibility and Assessment of a Cascade Traceback Screening program (FACTS): protocol for a multisite study to implement and assess an ovarian cancer traceback cascade testing program. J Pers Med. 2021 Jun 11;11(6):543. doi: 10.3390/jpm11060543. PubMed

Henrikson NB, Blasi P, Figueroa Gray M, Tiffany BT, Scrol A, Ralston JD, Fullerton SM, Lim CY, Ewing J, Leppig KA. Patient and family preferences on health system-led direct contact for cascade screening. J Pers Med. 2021;11(6):538. doi: 10.3390/jpm11060538. PubMed

Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(19):1978-1997. doi: 10.1001/jama.2021.4417. PubMed

Fan X, Wynn J, Shang N, Liu C, Fedotov A, Hallquist MLG, Buchanan AH, Williams MS, Smith ME, Hoell C, Rasmussen-Torvik LJ, Peterson JF, Wiesner GL, Murad AM, Jarvik GP, Gordon AS, Rosenthal EA, Stanaway IB, Crosslin DR, Larson EB, Leppig KA, Henrikson NB, Williams JL, Li R, Hebbring S, Weng C, Shen Y, Crew KD, Chung WK. Penetrance of breast cancer susceptibility genes from the eMERGE III network. JNCI Cancer Spectr. 2021 May 8;5(4):pkab044. doi: 10.1093/jncics/pkab044. eCollection 2021 Aug. PubMed

Henrikson NB, Scrol A, Leppig KA, Ralston JD, Larson EB, Jarvik GP. Preferences of biobank participants for receiving actionable genomic test results: results of a recontacting study. Genet Med. 2021 Jun;23(6):1163-1166. doi: 10.1038/s41436-021-01111-2. Epub 2021 Feb 18. PubMed

 

profile

Nora-Hendrikson-family_1col.jpg

Why does Nora Henrikson study patients’ cost of treatment?

Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.

video

Hendrikson-Nora-Cost-of-Care-ORCA_1col.jpg

Discussing patients’ concerns about cost of care

Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)

health services & economics

Tuzzio-Leah_1col.jpg

Community health workers can help make the difference for patients

Leah Tuzzio, MPH, and colleagues describe an underutilized role that can help primary care become truly patient-centered.

KPWHRI IN THE MEDIA

Cost-of-care conversations: How can health care be more transparent?

Avalere podcast, Feb. 22, 2019